Kevin C. O’Boyle
Member Board of Directors at Nevro
Mr. O’Boyle has over 20 years of executive management experience in the medical device industry. He was most recently Chairman of the Board of Directors at GenMark Diagnostics, a leading provider of sample-to-answer molecular diagnostic solutions acquired by Roche in March 2021. He has served in multiple leadership roles at Advanced BioHealing, Inc., NuVasive, Inc., and ChromaVision Medical Systems, Inc. Mr. O’Boyle is currently a member of the Board of Directors at Nevro and Sientra.